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In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article. antigen [1] . The expression of IR has been associated to T-cell exhaustion in autoimmune 65 diseases, chronic infections and cancers and to the impotence of T-cells to eradicate tumors 66 to UCa patients showed that BTLA was significantly overexpressed by CD141 + DC and pDC, 94 whereas only a slight increase of TIM-3 expression was observed in CD141 + DC (Fig. 1A) . 95
Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors 1 in Urothelial Cancer
This result suggests that bladder tumor microenvironment may increase BTLA and TIM-3 96 expression on DC. In order to have more insights into BTLA and TIM-3 expression by DC, 97
we segregated the data from UCa patients in two groups, according to the stage of the disease 98 (Supplementary Table 1 ): non-muscle invasive bladder cancer (NMIBC) and MIBC patients. 99
A significantly higher expression of TIM-3 was only found in CD141 + DC from MIBC 100 patients as compared to HD, suggesting that UCa-mediated overexpression of TIM-3 is later 101 than for BTLA, which was overexpressed in CD141 + DC and pDC from both types of patients 102 (Supplementary Fig. 2 (Fig. 1B) . Notably, we observed a significant overexpression of TIM-3 109 in both types of bladder DC and a higher frequency of BTLA + CD14 neg CD11c + bladder DC 110 within tumor tissue (Fig. 1C) . Similar results were obtained when comparing non-paired 111 tissue samples (Supplementary Fig. 3) . 112
We next sought to determine whether BTLA and TIM-3 expressed on DC are functional 113 and could lead to an inhibition of DC function, as monitored by cytokine (IL-12, IL-1β and 114 TNF-α) production, upon recombinant HVEM (BTLA ligand) or galectin-9 (TIM-3 ligand) 115 binding. Thus, sorted CD1c + and CD141 + DC were stimulated by polyionosinic-polycytidylic 116 acid (Poly(I:C)) and pDC by CpG oligodeoxynucleotides (CpG ODN). In the presence of 117 either HVEM or galectin-9, we observed a decrease of the cytokine secretion by CD141 + DC 118 (Fig. 2A) . In addition, CD1c + DC produced less IL-12p70 and IL-1β upon galectin-9 ligation 119 (Fig. 2B) . In pDC, only IL-12p70 production was affected by the presence of HVEM (Fig.  120   2C) . These data suggest a functional inhibition of DC subpopulations via BTLA/HVEM or 121 TIM-3/galectin-9 interactions. 122
In this study, we present the first analysis of several IR on DC subsets from HD and UCa 123 patients. We found that BTLA and TIM-3 are differentially expressed across circulating and 
Supplementary materials and methods

Patient selection
Buffy coats from healthy subjects were purchased from the Blood Transfusion Center, Epalinges, Switzerland. Peripheral blood and bladder tissue from patient were obtained after written consent and full ethics approval (protocol #119/10). Bladder tissue samples were carefully collected by pathologist from tumor and non-tumoral adjacent tissue at a resection margin located at a mean distance of 2 cm from the tumor. Bladder cells were then fractionated as described previously [1] and were subsequently used for flow cytometry analysis. The pathological characteristics of patients are summarized in Supplementary Table   1 .
Flow cytometry and cell sorting
The following antibodies to human proteins were used. From Biolegend: anti-CD1c-PerCP- 
Statistical analysis
Statistical analysis was performed using GraphPad Prism 6 and included unpaired (Supplemental Fig.2 ) or paired ( Fig. 1C and 2 ) two-tailed Student's t-test or one-way ANOVA followed by Dunnett's test (Fig. 1A) for comparing the means of two or multiple groups, respectively. p values below 0.05 were considered statistically significant.
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